Profusa

Closed (deSPAC)

Profile in progress

What it is: Based in Berkeley, CA, Profusa is a commercial stage digital health company led by visionary scientific founders, an experienced management team and a world-class board of directors in the development of a new generation of tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data for personal and medical use
What it’s doing now: Merging with NorthView Acquisition Corp (NVAC) — closed (despac).
What you should know: The deal carries a $15M minimum-cash condition — heavy redemptions can break it.

The business, per its filings

SEC primary

Based in Berkeley, CA, Profusa is a commercial stage digital health company led by visionary scientific founders, an experienced management team and a world-class board of directors in the development of a new generation of tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data for personal and medical use. With its long-lasting, injectable and affordable biosensors and its intelligent data platform, Profusa aims to provide people with a personalized biochemical signature rooted in data that clinicians can trust and rely on. “LUMEE”, “PROFUSA” and the PROFUSA logo are registered trademarks of Profusa, Inc. in the United States, Canada, European Union, China, Japan, South Korea and Australia. For more information, visit https://profusa.com. Special Note Regarding

What the company says about itself

Web research — not audited

Profusa develops the Lumee platform, which uses a biologically compatible injectable hydrogel microsensor to continuously monitor body chemistry from inside the tissue. The platform includes Oxygen monitoring for Critical Limb Ischemia (CLI), Glucose monitoring, and a Data Discovery Platform for AI-backed clinical insights.

Markets:: Healthcare | Medical Devices | Wound Care | Diabetes Management
Products:: Lumee™ Oxygen | Lumee™ Glucose | Data Discovery Platform

Source: https://profusa.com/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.

The deal it’s entering

Profusa is merging with NorthView Acquisition Corp (NVAC) currently marked Closed (deSPAC).

Headline equity value	—
Minimum cash to close	$15M

Structure per SEC accession(s) 0001140361-23-002759. How to read these numbers: headline vs effective valuation · what a definitive agreement commits

What exactly is being valued, and at what

Common questions

Is Profusa going public?

Profusa has an approved merger with the SPAC NorthView Acquisition Corp (NVAC). Deal status: Closed (deSPAC).

Does Profusa have revenue?

The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.

Educational content, not investment advice.